Counterfeit Version of Avastin In U.S. Distribution

The FDA announced a warning to healthcare professionals and patients about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical practices in the United States.

The counterfeit version is labeled as Avastin, manufactured by Roche and does not contain the medicine's active ingredient, bevacizumab, which my have resulted in patients not receiving needed therapy. 

Avastin is an injectable medicine used to treat various types of cancer, including brain cancer, and is administered to patients in clinics, hospitals, and doctors' offices.

Click here for FDA announcement.

 

Share |
March 19, 2015 09:35 PM
Proceeds from the Florida Brain Cancer 5k support this ongoing partnership.
March 18, 2015 04:41 PM
ABC2 is working with Matt de Silva, co-founder of Notable Labs, to advance personalized treatments for brain cancer.

Join us in our fight for a cure!

Twitter